Top 5 Medtech[y] Stories From the Week: August 28 2016
Posted on August 28, 2016 by Medtech[y] Staff
Most Read Articles From the Week
We have assembled our most read articles from the week. Check back throughout the week to read interesting stories from the Medical Device and Pharmaceutical industries as well as stories on how to become more effective in the medical sales field.
Medtronic reported earnings this week and we have their full earnings presentation available to review.
A number of sales reps think sales success happens because you can schmooze and are a likable person. There is no doubt those factors can lead to one-off successes, but long-term success in sales is due to strategy and planning.
Johnson & Johnson subsidiary, Ethicon, announced a strategic collaboration with Touch Surgery to help improve patient outcomes by delivering simulated surgical training of Ethicon products in a free mobile app for medical professionals.
Many device reps will agree that one of the best things about their jobs are the relationships they build with their customers. Device reps spend hours in surgery with surgeons and can become an integral part of the team.
A new study looked to see how deep those relationships go.
Intuitive Surgical filed a complaint last week against Johnson & Johnson subsidiary, Ethicon, for using "intricate gymnastics" to workaround California's labor mobility laws after Ethicon filed a complaint in Ohio against a California based sales rep who left Ethicon for Intuitive.
Popular Thread From the Week
Muddy Waters Capital is short St. Jude Medical, Inc. (STJ US). There is a strong possibility that close to half of STJ's revenue is about to disappear for approximately two years. STJ's pacemakers, ICDs, and CRTs might - and in our view, should - be recalled and remediated. (These devices collectively were 46% of STJ"s 2015 revenue.) Based on conversations with industry experts, we estimate remediation would take at least two years. Even lacking a recall, the product safety issues we present in this report offer unnecessary health risks and should receive serious notice among hospitals, physicians and cardiac patients.
Thanks for reading and helping Medtech[y] continue to grow!